GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers must balance this potential with challenges such as high upfront spend, adherence issues, and determining which patients will benefit most. Read a more in-depth overview of these considerations in our previous blog post. Managing these…

Read More

Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally developed for diabetes and now widely used for weight management, are rapidly reshaping clinical care with far-reaching impacts on chronic disease management, weight loss, and cardiovascular health. Despite long-term benefits, the prescribing of GLP-1s must…

Read More

Key takeaways from The Sequoia Project’s 2025 Annual Meeting to speed up healthcare data interoperability   I recently attended The Sequoia Project’s 2025 Annual Meeting in Nashville. The Sequoia Project was formed in 2012 with the launch of its first initiative, a federal health information network. They help healthcare organizations and government bodies accelerate the…

Read More
optimizing employee health

Controlling employee healthcare costs while maintaining a healthy and productive workforce is a top priority for today’s employers. Traditional approaches however are no longer sufficient in the face of rising expenses and evolving regulatory requirements. Don’t worry, though. There is a solution: advanced healthcare analytics. It’s become a non-negotiable capability for companies to maintain fiscal…

Read More